Goldman Sachs Upgrades Passage Bio Inc. (PASG) to Buy
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Price: $14.45 +5.01%
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 5 | New: 41
Rating Summary:
8 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 5 | New: 41
Trade Now!
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter upgraded Passage Bio Inc. (NASDAQ: PASG) from Neutral to Buy with a price target of $30.00 (from $28.00).
For an analyst ratings summary and ratings history on Passage Bio Inc. click here. For more ratings news on Passage Bio Inc. click here.
Shares of Passage Bio Inc. closed at $19.96 yesterday.
You May Also Be Interested In
- UPDATE: RBC Capital Upgrades GMS Inc. (GMS) to Outperform
- Jefferies Upgrades Martin Marietta Materials (MLM) to Buy
- Dankse Bank A/S (DANSK:DC) (DNSKF) PT Raised to DKK130 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
